Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a ...

Vector Science & Therapeutics Corp. (TSXV: PAIN) (the "Company") today announced the appointment of Russell Starr as President of the Company, effective October 5, 2026. Bill Jackson will continue to ...

Vector Science and Therapeutics Corp. ( PAIN.V) has entered into a strategic relationship with Whoopi Wellness, Inc., a subsidiary of WhoopFam LLC co-founded by Whoopi Goldberg, including an ...

Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a strategic relationship with Scoreboard, Inc. ("Scoreboard"), a performance ...

Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology MEQUON, Wis., April 30, 2026 ...

Vector Science and Therapeutics Corp. ( PAIN.V ), a medical technology company developing drug delivery technology and pharma-grade peptide manufacturing, has entered into a strategic relationship ...

Vector Science and Therapeutics Corp. ( ($TSE:PAIN) ) has provided an update. Vector Science & Therapeutics Corp. has appointed capital markets veteran and ...

Vector Science & Therapeutics Corp. announced the appointment of Russell Starr as President of the Company, effective October 5, 2026. Bill Jackson will continue to serve as Chief Executive Officer.

14-Year MLB Veteran and 2016 World Series Champion Joins Valor, Vector's Athlete Platform, to Make Sure the Next Generation Plays Longer and Hurts Less MEQUON, Wis., June 12, 2026 /PRNewswire/ -- ...

Investment advances collaboration on peptide-based products for athletic performance, recovery and longevity TORONTO, Oct. 7, 2026 /PRNewswire/ -- Vector Science and ...